Table 1.

Total Cases, Average Annual age-adjusted Incidence Rate^a (AAAIR), Incidence Rate Ratio^a (IRR), and 95% Confidence Interval (CI) for Meningioma by Sex and Stratified by 10-year Age Intervals (CBTRUS: Data provided by CDC’s National Program of Cancer Registries and NCI’s Surveillance, Epidemiology and End Results Program, 2004-2019)

Age Group	Sex	Total Cases (2004–2019)	AAAIR (95% CI)	IRR (95% CI)	IRR P-value
0–9	Male	187	0.06 (0.05–0.07)	Ref	.4168
	Female	196	0.06 (0.05–0.07)	1.09 (0.89–1.34)
10–19	Male	662	0.19 (0.18–0.21)	Ref	.0020
	Female	746	0.22 (0.21–0.24)	1.18 (1.06–1.31)
20–29	Male	2112	0.60 (0.57–0.62)	Ref	<.0001
	Female	3864	1.13 (1.09–1.17)	1.89 (1.79–1.99)
30–39	Male	5262	1.62 (1.57–1.66)	Ref	<.0001
	Female	15 748	4.87 (4.79–4.95)	3.01 (2.92–3.11)
40–49	Male	11 253	3.29 (3.22–3.35)	Ref	<.0001
	Female	38 766	11.10 (10.99–11.22)	3.38 (3.31–3.45)
50–59	Male	20 459	6.21 (6.13–6.30)	Ref	<.0001
	Female	62 663	18.20 (18.06–18.35)	2.93 (2.88–2.98)
60–69	Male	28 438	12.29 (12.14–12.43)	Ref	<.0001
	Female	73 835	28.76 (28.55–28.97)	2.34 (2.31–2.37)
70–79	Male	28 931	22.25 (21.99–22.50)	Ref	<.0001
	Female	69 817	43.47 (43.15–43.80)	1.95 (1.93–1.98)
80+	Male	23 328	34.44 (34.00–34.89)	Ref	<.0001
	Female	65 156	55.94 (55.50–56.37)	1.62 (1.60–1.65)

Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States.

^aRates are per 100 000 and are age-adjusted to the 2000 US standard population.